Enalapril Maleate Tablets, USP; 2.5 mg; 90 tablets, NDC 60429-183-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA, USA.
Golden State Medical Supply
CGMP Deviations
Prescription and over-the-counter medications
Golden State Medical Supply
CGMP Deviations
Wedgewood Village Pharmacy
Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
Wedgewood Village Pharmacy
Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
Golden State Medical Supply
CGMP Deviations
Golden State Medical Supply
CGMP Deviations
Wedgewood Village Pharmacy
Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
Microbial Contamination of a Non-Sterile Products: Testing of product onfirmed the presence of Gluconacetobacter Liquefaciens
Golden State Medical Supply
CGMP Deviations
Wedgewood Village Pharmacy
Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.
Glenmark Pharmaceuticals Inc., USA
Defective Container
Wedgewood Village Pharmacy
Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
Wedgewood Village Pharmacy
Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
Defective container: defect prevents product from dispensing as intended.
Green Pharmaceuticals
Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.
Buzzagogo
Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain elevated levels of yeast and mold as well as the presence of Bacillus cereus.
Defective Delivery System: Potential defect that could prevent the product from dispensing as intended.